Format
Sort by

Send to

Choose Destination

Search results

Items: 20

1.

Participant Experiences in the Environmental Determinants of Diabetes in the Young Study: Common Reasons for Withdrawing.

Lernmark B, Lynch K, Baxter J, Roth R, Simell T, Smith L, Swartling U, Johnson SB; Teddy Study Group..

J Diabetes Res. 2016;2016:2720650. doi: 10.1155/2016/2720650.

2.

Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study.

Uusitalo U, Liu X, Yang J, Aronsson CA, Hummel S, Butterworth M, Lernmark Å, Rewers M, Hagopian W, She JX, Simell O, Toppari J, Ziegler AG, Akolkar B, Krischer J, Norris JM, Virtanen SM; TEDDY Study Group..

JAMA Pediatr. 2016 Jan;170(1):20-8. doi: 10.1001/jamapediatrics.2015.2757.

3.

Effects of Gluten Intake on Risk of Celiac Disease: A Case-Control Study on a Swedish Birth Cohort.

Andrén Aronsson C, Lee HS, Koletzko S, Uusitalo U, Yang J, Virtanen SM, Liu E, Lernmark Å, Norris JM, Agardh D; TEDDY Study Group..

Clin Gastroenterol Hepatol. 2016 Mar;14(3):403-409.e3. doi: 10.1016/j.cgh.2015.09.030.

PMID:
26453955
4.

A method for reporting and classifying acute infectious diseases in a prospective study of young children: TEDDY.

Lönnrot M, Lynch K, Larsson HE, Lernmark Å, Rewers M, Hagopian W, She JX, Simell O, Ziegler AG, Akolkar B, Krischer J, Hyöty H; TEDDY Study Group..

BMC Pediatr. 2015 Mar 20;15:24. doi: 10.1186/s12887-015-0333-8.

5.

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months.

Sosenko JM, Skyler JS, Beam CA, Boulware D, Mahon JL, Krischer JP, Greenbaum CJ, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups..

Diabetes Care. 2015 May;38(5):940-2. doi: 10.2337/dc14-2787.

6.

Clinical features of celiac disease: a prospective birth cohort.

Agardh D, Lee HS, Kurppa K, Simell V, Aronsson CA, Jörneus O, Hummel M, Liu E, Koletzko S; TEDDY Study Group..

Pediatrics. 2015 Apr;135(4):627-34. doi: 10.1542/peds.2014-3675.

7.

Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).

Steck AK, Vehik K, Bonifacio E, Lernmark A, Ziegler AG, Hagopian WA, She J, Simell O, Akolkar B, Krischer J, Schatz D, Rewers MJ; TEDDY Study Group..

Diabetes Care. 2015 May;38(5):808-13. doi: 10.2337/dc14-2426.

8.

Age at gluten introduction and risk of celiac disease.

Aronsson CA, Lee HS, Liu E, Uusitalo U, Hummel S, Yang J, Hummel M, Rewers M, She JX, Simell O, Toppari J, Ziegler AG, Krischer J, Virtanen SM, Norris JM, Agardh D; TEDDY STUDY GROUP..

Pediatrics. 2015 Feb;135(2):239-45. doi: 10.1542/peds.2014-1787.

9.

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history.

Sosenko JM, Skyler JS, DiMeglio LA, Beam CA, Krischer JP, Greenbaum CJ, Boulware D, Rafkin LE, Matheson D, Herold KC, Mahon J, Palmer JP; Type 1 Diabetes TrialNet Study Group.; Diabetes Prevention Trial-Type 1 Study Group..

Diabetes Care. 2015 Feb;38(2):271-6. doi: 10.2337/dc14-1813.

10.

Early childhood gut microbiomes show strong geographic differences among subjects at high risk for type 1 diabetes.

Kemppainen KM, Ardissone AN, Davis-Richardson AG, Fagen JR, Gano KA, León-Novelo LG, Vehik K, Casella G, Simell O, Ziegler AG, Rewers MJ, Lernmark Å, Hagopian W, She JX, Krischer JP, Akolkar B, Schatz DA, Atkinson MA, Triplett EW; TEDDY Study Group..

Diabetes Care. 2015 Feb;38(2):329-32. doi: 10.2337/dc14-0850.

11.

Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.

Törn C, Hadley D, Lee HS, Hagopian W, Lernmark Å, Simell O, Rewers M, Ziegler A, Schatz D, Akolkar B, Onengut-Gumuscu S, Chen WM, Toppari J, Mykkänen J, Ilonen J, Rich SS, She JX, Steck AK, Krischer J; TEDDY Study Group..

Diabetes. 2015 May;64(5):1818-29. doi: 10.2337/db14-1497.

12.

Maternal anxiety about a child's diabetes risk in the TEDDY study: the potential role of life stress, postpartum depression, and risk perception.

Roth R, Lynch K, Lernmark B, Baxter J, Simell T, Smith L, Swartling U, Ziegler AG, Johnson SB; TEDDY Study Group..

Pediatr Diabetes. 2015 Jun;16(4):287-98. doi: 10.1111/pedi.12168.

13.

Risk of pediatric celiac disease according to HLA haplotype and country.

Liu E, Lee HS, Aronsson CA, Hagopian WA, Koletzko S, Rewers MJ, Eisenbarth GS, Bingley PJ, Bonifacio E, Simell V, Agardh D; TEDDY Study Group..

N Engl J Med. 2014 Jul 3;371(1):42-9. doi: 10.1056/NEJMoa1313977. Erratum in: N Engl J Med. 2014 Jul 24;371(4):390.

14.

Prevalence of obesity was related to HLA-DQ in 2-4-year-old children at genetic risk for type 1 diabetes.

Yang J, Lernmark Å, Uusitalo UM, Lynch KF, Veijola R, Winkler C, Larsson HE, Rewers M, She JX, Ziegler AG, Simell OG, Hagopian WA, Akolkar B, Krischer JP, Vehik K; TEDDY Study Group..

Int J Obes (Lond). 2014 Dec;38(12):1491-6. doi: 10.1038/ijo.2014.55.

15.

Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study.

Lee HS, Burkhardt BR, McLeod W, Smith S, Eberhard C, Lynch K, Hadley D, Rewers M, Simell O, She JX, Hagopian B, Lernmark A, Akolkar B, Ziegler AG, Krischer JP; TEDDY study group..

Diabetes Metab Res Rev. 2014 Jul;30(5):424-34. doi: 10.1002/dmrr.2510.

16.

Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease.

Elding Larsson H, Vehik K, Gesualdo P, Akolkar B, Hagopian W, Krischer J, Lernmark Å, Rewers M, Simell O, She JX, Ziegler A, Haller MJ; TEDDY Study Group..

Pediatr Diabetes. 2014 Mar;15(2):118-26. doi: 10.1111/pedi.12066.

17.

Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants.

Sosenko JM, Skyler JS, Beam CA, Krischer JP, Greenbaum CJ, Mahon J, Rafkin LE, Matheson D, Herold KC, Palmer JP; Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups..

Diabetes. 2013 Dec;62(12):4179-83. doi: 10.2337/db13-0656.

18.

The prediction of type 1 diabetes by multiple autoantibody levels and their incorporation into an autoantibody risk score in relatives of type 1 diabetic patients.

Sosenko JM, Skyler JS, Palmer JP, Krischer JP, Yu L, Mahon J, Beam CA, Boulware DC, Rafkin L, Schatz D, Eisenbarth G; Type 1 Diabetes TrialNet Study Group.; Diabetes Prevention Trial-Type 1 Study Group..

Diabetes Care. 2013 Sep;36(9):2615-20. doi: 10.2337/dc13-0425.

19.

Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.

Yu L, Boulware DC, Beam CA, Hutton JC, Wenzlau JM, Greenbaum CJ, Bingley PJ, Krischer JP, Sosenko JM, Skyler JS, Eisenbarth GS, Mahon JL; Type 1 Diabetes TrialNet Study Group..

Diabetes Care. 2012 Jun;35(6):1213-8. doi: 10.2337/dc11-2081.

20.

The Environmental Determinants of Diabetes in the Young (TEDDY) Study.

TEDDY Study Group..

Ann N Y Acad Sci. 2008 Dec;1150:1-13. doi: 10.1196/annals.1447.062.

Items per page

Supplemental Content

Loading ...
Support Center